Has Amanda Kimmel, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $11,043 in general payments to Amanda Kimmel, APRN across 441 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amanda Kimmel, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amanda Kimmel, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amanda Kimmel, APRN

Adult Health · Tampa, FLNPI 1609461581

Payments from drug & device makers

$11,043in general payments, 2019–2025

Across 441 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$3K
Bayer$638
Merck$555
Pfizer$530
AstraZeneca$519
E.r. Squibb & Sons, L.L.C.$486
plus $6K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	64	$2,594
Bayer	22	$638
Merck	26	$555
Pfizer	25	$530
AstraZeneca(2 entities)	18	$519
E.r. Squibb & Sons, L.L.C.	27	$486
Gilead(2 entities)	21	$440
Eisai Inc.	21	$436
Bristol Myers Squibb	20	$432
Johnson & Johnson	18	$414
AbbVie	12	$355
Astellas Pharma US Inc	12	$287
Takeda Pharmaceuticals U.S.A., Inc.	9	$253
Incyte Corporation	11	$247
Seagen Inc.	11	$177
GSK	8	$170
Lilly USA, LLC	8	$163
Stemline Therapeutics Inc.	7	$161
Array Biopharma Inc	9	$156
Beigene USA, Inc.	6	$151
Regeneron Healthcare Solutions, Inc.	6	$134
AVEO Pharmaceuticals, Inc.	6	$111
Rigel Pharmaceuticals, Inc.	3	$98
Amgen	5	$96
Boehringer Ingelheim	4	$85
Sobi, Inc	4	$83
Jazz Pharmaceuticals Inc.	4	$82
Sirtex Medical Inc	2	$81
Pharmaessentia USA Corporation	3	$73
Sanofi	3	$70
Genmab U.S., Inc.	3	$69
Legend Biotech USA Inc.	2	$63
Exelixis Inc.	3	$63
Pharmacosmos Therapeutics Inc.	3	$62
Genentech USA, Inc.	3	$60
CTI Biopharma Corp.	3	$60
Deciphera Pharmaceuticals Inc.	3	$56
Tersera Therapeutics LLC	2	$53
Beone Medicines USA, Inc.	2	$53
Ipsen Biopharmaceuticals, Inc	3	$52
Myovant Sciences Inc.	3	$50
Puma Biotechnology, Inc.	2	$39
Sumitomo Pharma America, Inc.	2	$35
Karyopharm Therapeutics Inc.	2	$33
EMD Serono, Inc.	2	$30
Immunocore Limited	1	$29
Telix Pharmaceuticals	1	$25
Iovance Biotherapeutics, Inc.	1	$24
Daiichi Sankyo Inc.	1	$23
Dendreon Pharmaceuticals LLC	1	$23
Syndax Pharmaceuticals, Inc.	1	$22
AMAG Pharmaceuticals, Inc.	1	$21
Acceleron Pharma, Inc.	1	$18

How this compares

$11,043 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida →

Medicare billing

Part B allowed, 2024

$19,248

Medicare patients

Services billed

2,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Tampa

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →